ENTRY       D04499                      Drug
NAME        Idursulfase (USAN/INN);
            Idursulfase (genetical recombination) (JAN);
            Elaprase (TN)
PRODUCT     ELAPRASE (Takeda Pharmaceuticals America)
SEQUENCE    SETQANSTTD ALNVLLIIVD DLRPSLGCYG DKLVRSPNID QLASHSLLFQ NAFAQQAVCA
            PSRVSFLTGR RPDTTRLYDF NSYWRVHAGN FSTIPQYFKE NGYVTMSVGK VFHPGISSNH
            TDDSPYSWSF PPYHPSSEKY ENTKTCRGPD GELHANLLCP VDVLDVPEGT LPDKQSTEQA
            IQLLEKMKTS ASPFFLAVGY HKPHIPFRYP KEFQKLYPLE NITLAPDPEV PDGLPPVAYN
            PWMDIRQRED VQALNISVPY GPIPVDFQRK IRQSYFASVS YLDTQVGRLL SALDDLQLAN
            STIIAFTSDH GWALGEHGEW AKYSNFDVAT HVPLIFYVPG RTASLPEAGE KLFPYLDPFD
            SASQLMEPGR QSMDLVELVS LFPTLAGLAG LQVPPRCPVP SFHVELCREG KNLLKHFRFR
            DLEEDPYLPG NPRELIAYSQ YPRPSDIPQW NSDKPSLKDI KIMGYSIRTI DYRYTVWVGF
            NPDEFLANFS DIHAGELYFV DSDPLQDHNM YNDSQGGDLF QLLMP
  TYPE      Peptide
REMARK      Therapeutic category: 3959
            ATC code: A16AB09
            Product: D04499<JP/US>
EFFICACY    Lysosomal storage disease treatment, Enzyme replacement (iduronate-2-sulfatase)
  DISEASE   Hunter syndrome [DS:H00129]
  TYPE      Enzyme replacement therapy product
TARGET      IDS* [HSA_VAR:3423v1] [HSA:3423] [KO:K01136]
  PATHWAY   hsa00531(3423)  Glycosaminoglycan degradation
            hsa04142(3423)  Lysosome
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
               A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
                A16AB Enzymes
                 A16AB09 Idursulfase
                  D04499  Idursulfase (USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
              Idursulfase
               D04499  Idursulfase (USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               395  Enzyme preparations
                3959  Others
                 D04499  Idursulfase (USAN/INN); Idursulfase (genetical recombination) (JAN)
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Hydrolases (EC3)
               Sulfatases
                IDS* [HSA_VAR:3423v1]
                 D04499  Idursulfase (USAN/INN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D04499
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D04499
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D04499
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D04499
            Pharmacogenomic biomarkers [br08341.html]
             Germline mutations in genetic disorder treatments
              D04499
DBLINKS     CAS: 50936-59-9
            PubChem: 47206347
///
